Kineticos Disruptor — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Orthobondorthobond.cominAug 2026SEC filingmedium confidence
Orthobond develops proprietary antimicrobial nanosurface technology that covalently binds to metallic and polymeric surfaces to mechanically kill bacteria, viruses, and fungi without antibiotics or eluting chemicals.
HealthtechMedical DevicesNew MaterialsMonmouth Junction, US
David Nichols(CEO)inPeter Goodwin(Director)Frank Cammisa(Director)Khalil Barrage(Director)Lisa D'Urso(Director)David Helfet(Director)
Board seatShailesh Maingi· per SEC Form D · $10M raise · filed Sep 2026
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.